Survival after ultramassive transfusion: a review of 1360 cases

Author:

Dzik Walter Sunny1,Ziman Alyssa2,Cohen Claudia3,Pai Menaka4,Lozano Miguel5,Kaufman Richard M.6,Delaney Meghan7,Selleng Kathleen8,Murphy Michael F.9,Hervig Tor10,Yazer Mark11,

Affiliation:

1. Massachusetts General Hospital; Boston Massachusetts

2. Department of Pathology and Laboratory Medicine, Division of Transfusion Medicine; UCLA Medical Center; Los Angeles California

3. Lab Medicine and Pathology; University of Minnesota Medical Center; Minneapolis Minnesota

4. Medicine and Department of Pathology and Molecular Medicine; McMaster University; Hamilton Ontario Canada

5. Hemotherapy and Hemostasis; University Clinic Hospital; Barcelona Spain

6. Pathology; Brigham and Women's Hospital; Boston Massachusetts

7. Laboratory Medicine; University of Washington, and Puget Sound Blood Center; Seattle Washington

8. Institut for Immunology and Transfusion Medicine; Ernst-Moritz-Arndt-University; Greifswald Germany

9. John Radcliffe Hospital; NHS Blood & Transplant; Oxford UK

10. Transfusion Medicine; Haukeland University Hospital; Bergen Norway

11. Institute for Transfusion Medicine; Pittsburgh Pennsylvania

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Reference16 articles.

Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3